News
CRISPR Therapeutics is revolutionizing medicine with gene editing. Learn more about CRSP's breakthroughs, stock rally, and ...
7h
Zacks Investment Research on MSNIs It Worth Investing in CRISPR Therapeutics (CRSP) Based on Wall Street's Bullish Views?Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a ...
Rare genetic diseases are challenging for patients and their families—made all the more overwhelming because symptoms tend to ...
A Ph.D. graduate student in biomolecular engineering at UC Santa Cruz, with a background in computer science and mathematics, ...
Advancements in gene editing, strategic partnerships, and supportive regulations fuel global CRISPR adoption across healthcare and agriculture. DELAWARE, DE, UNITED STATES, July 14, 2025 /EINPresswire ...
Analysts have also weighed in on stock throughout the month. Recent analyst calls on the stock include: Needham analyst Gil ...
6don MSN
A Ph.D. student in biomolecular engineering at the University of California, Santa Cruz, has built a software program ...
A glucose-sensitive nanovaccine delivers CRISPR to tumors, silences immune-suppressing genes, and activates a targeted immune response against cancer.
Scientists have created a near-copy of the long-extinct dire wolf. Using advanced CRISPR gene editing tech, it now looks ...
CRISPR is revolutionizing medicine by enabling precise DNA edits, treating genetic diseases like sickle cell anemia and ...
The Byers Award recognizes outstanding research by faculty members in the middle of their careers. Martin Kampman’s honorary ...
13don MSN
Genome editing technologies like CRISPR-Cas9 have transformed biology, medicine, and agriculture, but concerns remain about ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results